US71716E1055
© Globe Newswire
01.02.2026
PHAR
LISTED
NASDAQ
Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS
News Preview
Pharming Group received an FDA Complete Response Letter for its sNDA for Joenja® (leniolisib) in children aged 4–11 with APDS...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
PHAR
LISTED
NASDAQ
Pharming Group reports preliminary 2025 revenues and announces Investor Day
News Preview
Pharming announced preliminary, unaudited revenues for the full year 2025 and plans to host a virtual Investor Day on February 3, 2026 at 10:00 EST....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.12.2025
PHAR
LISTED
NASDAQ
Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit
News Preview
Pharming to participate in Oppenheimer Movers in Rare Disease Summit on Dec 11 in NYC. Chief Medical Officer Anurag Relan in fireside chat at 1:50 PM ET....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
06.11.2025
PHAR
LISTED
NASDAQ
Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow
News Preview
Pharming Group reports Q3 2025 results with significant growth in revenue, profit, and cash flow driven by rare disease portfolio performance....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© Globe Newswire
30.10.2025
PHAR
LISTED
NASDAQ
Pharming Group to participate in Fireside Chat at Jefferies Global Healthcare Conference in London
News Preview
Pharming CEO will participate in Fireside Chat on Nov. 19 at the Jefferies Global Healthcare Conference being held in London Nov. 17-20, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
23.10.2025
PHAR
LISTED
NASDAQ
Pharming Group to report third quarter 2025 financial results and provide business update on November 6
News Preview
Pharming to report third quarter 2025 financial results and provide a business update on November 6, 2025, and host conference call at 13:30 CET/07:30 ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
20.10.2025
PHAR
LISTED
NASDAQ
Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio
News Preview
Pharming announces 12 abstracts have been accepted for presentation at 2025 ACAAI Annual Scientific meeting being held in Orlando, Florida on November 6-10...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.10.2025
PHAR
LISTED
NASDAQ
Pharming Group provides update on previously announced G&A expense reduction plan
News Preview
Pharming provides update on previously announced G&A expense reduction plan...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2025
PHAR
LISTED
NASDAQ
Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years
News Preview
Pharming sNDA for leniolisib in children aged 4-11 years with APDS accepted and granted Priority Review by FDA....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.09.2025
PHAR
LISTED
NASDAQ
Pharming Group promoted to the Euronext AMX® index
News Preview
Leiden, the Netherlands, September 10, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced that it has been promoted from the Euronext AScX® (Small Cap) to the AMX® (MidCap) index, effective from September 22, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
PHAR
LISTED
NASDAQ
Pharming Group to present at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Leiden, the Netherlands, September 3, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming management will participate in the H.C. Wainwright 27th Annual Global Investment Conference in New York on September 8-10, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
02.09.2025
PHAR
LISTED
NASDAQ
Pharming Group appoints Kenneth Lynard as Chief Financial Officer
News Preview
Leiden, the Netherlands, September 2, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced the appointment of Kenneth Lynard as Chief Financial Officer (CFO), effective October 1, 2025....
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
31.07.2025
PHAR
LISTED
NASDAQ
Pharming Group reports second quarter and first half 2025 financial results and provides business update
News Preview
Leiden, the Netherlands, July 31, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) presents its preliminary (unaudited) financial report for the second quarter and first half year ended June 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
17.07.2025
PHAR
LISTED
NASDAQ
Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31
News Preview
Leiden, the Netherlands, July 17, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the second quarter and first half 2025 and provide a business update on Thursday, July 31, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
24.06.2025
PHAR
LISTED
NASDAQ
Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis
News Preview
For media and investors only...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.06.2025
PHAR
LISTED
NASDAQ
Pharming Group reports on results of the 2025 Annual General Meeting of Shareholders
News Preview
Leiden, the Netherlands, June 11, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces that at its Annual General Meeting of Shareholders (AGM) held today, all proposals were approved....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.05.2025
PHAR
LISTED
NASDAQ
Pharming Group to participate in June investor conferences
News Preview
Leiden, the Netherlands, May 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month of June:...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.05.2025
PHAR
LISTED
NASDAQ
Pharming Group reports first quarter 2025 financial results and provides business update
News Preview
Leiden, the Netherlands, May 8, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) presents its preliminary unaudited financial report for the three months ended March 31, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
24.04.2025
PHAR
LISTED
NASDAQ
Pharming Group to report first quarter 2025 financial results on May 8
News Preview
Leiden, the Netherlands, April 24, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) first quarter 2025 financial results, for the period ended March 31, on Thursday, May 8, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
23.04.2025
PHAR
LISTED
NASDAQ
Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS
News Preview
For media and investors only...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.04.2025
PHAR
LISTED
NASDAQ
Pharming Group announces the filing of its 2024 Annual Report and Form 20-F
News Preview
Leiden, the Netherlands, April 3, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces the filing of its Annual Report for the year ended December 31, 2024 (the “Period”). The Annual Report is available under Investors/Financial documents on the Pharming.com website....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.03.2025
PHAR
LISTED
NASDAQ
Pharming Group to participate in April investor conferences
News Preview
Leiden, the Netherlands, March 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month of April:...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.03.2025
PHAR
LISTED
NASDAQ
Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation
News Preview
Multi-center clinical trial includes sites located in the US, UK and EU...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.03.2025
PHAR
LISTED
NASDAQ
Pharming Group reports fourth quarter and full year 2024 financial results and provides business update
News Preview
Leiden, the Netherlands, March 13, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) presents its preliminary (unaudited) financial report for the three months and full year ended December 31, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.03.2025
PHAR
LISTED
NASDAQ
Pharming Group reports on results of the 2025 Extraordinary General Meeting of Shareholders
News Preview
Leiden, the Netherlands, March 4, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Extraordinary General Meeting of Shareholders (EGM) has adopted all proposals on the EGM agenda....
Themefolio
Profiler
Peergroup
© Globe Newswire
28.02.2025
PHAR
LISTED
NASDAQ
Pharming Group to participate in March investor conference
News Preview
Leiden, the Netherlands, February 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conference in the month of March:...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.02.2025
PHAR
LISTED
NASDAQ
Pharming Group to report fourth quarter and full year 2024 financial results on March 13
News Preview
Leiden, the Netherlands, February 27, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) fourth quarter and full year 2024 financial results, for the period ended December 31, on Thursday, March 13, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
20.02.2025
PHAR
LISTED
NASDAQ
Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent
News Preview
This press release is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.02.2025
PHAR
LISTED
NASDAQ
Pharming Group to participate in February investor conference
News Preview
Leiden, the Netherlands, February 10, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conference in the month of February:...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.02.2025
PHAR
LISTED
NASDAQ
Pharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of Abliva AB (publ) and extends the acceptance period
News Preview
This press release is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa or in any other jurisdiction where such offer pursuant to legislation and regulations in such relevant jurisdiction would be prohibited by applicable law. Shareholders not resident in Sweden who wish to accept the...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2025
PHAR
LISTED
NASDAQ
Pharming Group to convene Extraordinary General Meeting of Shareholders
News Preview
Leiden, the Netherlands, January 21, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces it will hold an Extraordinary General Meeting of Shareholders (EGM) on March 4, 2025, at 14:00 CET. The Notice to Convene, Explanatory Notes, Voting information, meeting documents and Form of Proxy can be f...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2025
PHAR
LISTED
NASDAQ
Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer
News Preview
Leiden, the Netherlands, January 21, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Board of Directors has nominated Fabrice Chouraqui to become Pharming’s new Executive Director and Chief Executive Officer, succeeding Sijmen de Vries....
Themefolio
Profiler
Peergroup
© Globe Newswire
15.12.2024
PHAR
LISTED
NASDAQ
Pharming announces public cash offer to the shareholders of Abliva AB
News Preview
Proposed acquisition strengthens Pharming’s late-stage pipeline with a potential first-in-disease asset...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.12.2024
PHAR
LISTED
NASDAQ
Pharming announces positive topline data in pediatric clinical trial of leniolisib
News Preview
Multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2024
PHAR
LISTED
NASDAQ
Pharming Group to participate in November investor conference
News Preview
Leiden, the Netherlands, November 5, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conference in the month of November:...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.10.2024
PHAR
LISTED
NASDAQ
Pharming Group reports third quarter 2024 financial results and provides business update
News Preview
Leiden, the Netherlands, October 24, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/NASDAQ: PHAR) presents its preliminary, unaudited financial report for the three months ended September 30, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2024
PHAR
LISTED
NASDAQ
Pharming Group to report third quarter 2024 financial results on October 24
News Preview
Leiden, the Netherlands, October 10, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) third quarter 2024 financial results, for the period ended September 30, on Thursday, October 24, 2024.Pharming will host a presentation for analysts and investors at 13:30 CEST/07:...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2024
PHAR
LISTED
NASDAQ
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation
News Preview
Proof of concept clinical trial will evaluate leniolisib in PIDs with immune dysregulation linked to altered PI3Kẟ signaling in lymphocytes...
Themefolio
Profiler
Peergroup
© Globe Newswire
26.09.2024
PHAR
LISTED
NASDAQ
Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)
News Preview
For media and investors only...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2024
PHAR
LISTED
NASDAQ
Pharming Group to participate in September investor conferences
News Preview
Leiden, the Netherlands, September 4, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the U.S. in the month of September:...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.08.2024
PHAR
LISTED
NASDAQ
Pharming Group reports second quarter and first half 2024 financial results and provides business update
News Preview
Leiden, the Netherlands, August 1, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) presents its preliminary (unaudited) financial report for the second quarter and first half year ended June 30, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
18.07.2024
PHAR
LISTED
NASDAQ
Pharming Group to report second quarter and first half 2024 financial results on August 1
News Preview
Leiden, the Netherlands, July 18, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) second quarter and first half 2024 financial results, for the period ended June 30, on Thursday, August 1, 2024.Pharming will host a presentation for analysts and investors at 13:30 CE...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.06.2024
PHAR
LISTED
NASDAQ
Pharming Group to participate in June investor conferences
News Preview
Leiden, the Netherlands, June 3, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month of June:...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.05.2024
PHAR
LISTED
NASDAQ
Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union
News Preview
Leiden, the Netherlands, May 30, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today an update on the ongoing review of its Marketing Authorisation Application (MAA) for leniolisib for the treatment of adult and pediatric patients 12 years of age and older with activated phosphoinositide...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.05.2024
PHAR
LISTED
NASDAQ
Pharming Group to participate in May investor conference
News Preview
Leiden, the Netherlands, May 20, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conference in the month of May:...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.05.2024
PHAR
LISTED
NASDAQ
Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025
News Preview
THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF BONDHOLDERS. IF BONDHOLDERS ARE IN ANY DOUBT AS TO THE ACTION THEY SHOULD TAKE, THEY SHOULD SEEK THEIR OWN FINANCIAL AND LEGAL ADVICE IMMEDIATELY FROM THEIR STOCKBROKER, SOLICITOR, ACCOUNTANT OR OTHER INDEPENDENT FINANCIAL OR LEGAL ADVISER. THIS NOTICE IS NOT FOR DISTRIBUTION IN OR TO...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.05.2024
PHAR
LISTED
NASDAQ
Pharming Group reports first quarter 2024 financial results and provides business update
News Preview
Leiden, the Netherlands, May 8, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) presents its preliminary (unaudited) financial report for the three months ended March 31, 2024....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
